2j4i: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 53: Line 53:
[[Category: zymogen]]
[[Category: zymogen]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 13:45:39 2007''
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 17:24:03 2007''

Revision as of 15:19, 30 October 2007

File:2j4i.gif


2j4i, resolution 1.8Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX

Overview

Structure-based drug design was exploited in the synthesis of, 3-(6-chloronaphth-2-ylsulfonyl)aminopyrrolidin-2-one-based factor Xa (fXa), inhibitors, incorporating an alanylamide P4 group with acyclic tertiary, amide termini. Optimized hydrophobic contacts of one amide substituent in, P4 were complemented by hydrophobicity-modulating features in the second, producing potent fXa inhibitors including examples with excellent, anticoagulant properties.

About this Structure

2J4I is a [Protein complex] structure of sequences from [Homo sapiens] with CA and GSJ as [ligands]. Active as [Coagulation factor Xa], with EC number [3.4.21.6]. Structure known Active Site: AC1. Full crystallographic information is available from [OCA].

Reference

Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs., Young RJ, Campbell M, Borthwick AD, Brown D, Burns-Kurtis CL, Chan C, Convery MA, Crowe MC, Dayal S, Diallo H, Kelly HA, King NP, Kleanthous S, Mason AM, Mordaunt JE, Patel C, Pateman AJ, Senger S, Shah GP, Smith PW, Watson NS, Weston HE, Zhou P, Bioorg Med Chem Lett. 2006 Dec 1;16(23):5953-7. Epub 2006 Sep 18. PMID:16982190

Page seeded by OCA on Tue Oct 30 17:24:03 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA